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Abstract Facial appearance is largely determined by the
morphology of the underlying skeleton. Hydroxyapatite is
one of several materials available to enhance projection of
the facial skeleton. This study evaluated the long-term
maintenance of augmented bony projection when porous
hydroxyapatite granules are used on the facial skeleton.
Ten female patients aged 28–58 years were studied fol-
lowing aesthetic augmentation of the facial skeleton at 24
sites using porous hydroxyapatite granules. Postoperative
CT scans at 3 months served as the baseline measurement
and compared with scans taken at 1 and 2 years, with the
thickness of the hydroxyapatite measured in axial and
coronal planes. Thickness of original bone plus overlay of
hydroxyapatite, thickness of the overlying soft tissue, and
the overall projection (bone plus soft tissue) were recorded.
It was found that 99.7% of the hydroxyapatite was main-
tained at 2 years, with no statistical difference (t test) from
the baseline measurement. The overall projection (bony
and soft tissue) was maintained as there was no evidence of
native bone resorption or soft tissue atrophy. Radiographic
results confirmed that the use of porous hydroxyapatite
granules for enhancement of the facial skeleton is not only
a predictable procedure, but maintains full bony projection
at 2 years.
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Facial appearance is largely determined by the morphology
and relative prominence of areas of the underlying skele-
ton. With aging, areas of the facial skeleton undergo
resorption contributing to laxity and descent of the soft
tissue. Prominent ‘‘cheekbones’’ are considered youthful
and prolong a younger appearance with aging [1–4] and a
well-defined mandibular rim is fundamental to having a
good and lasting neckline. Accordingly, surgical augmen-
tation of the skeleton significantly enhances a person’s
facial appearance and provides a more youthful look.
Augmentation of the facial skeleton has progressed since
the early use of onlay silicone implants to treat malar
asymmetries in the early 1960s [3]. The techniques devel-
oped initially for reconstructive surgery were employed for
aesthetic indications in the early 1970s and included the use
of both autogenous and alloplastic materials.
Autogenous bone grafts have been regarded as the pre-
ferred material for facial reconstruction. However, the dis-
advantages of donor site morbidity, limited moldability, and
unpredictable postoperative resorption have limited their
appeal for the aesthetic patient [5–8]. Accordingly, alloplas-
tic implants derived from polymers and ceramics, usually in
preformed shapes, have been favored in facial augmentation
for aesthetic purposes [5, 8–14]. Preformed silicone and
porous polyethylene (Medpor, Porex Corporation, Newman,
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GA) are currently the most used allografts. The recognized
risks with these are minimal but include malposition,
infection, thinning of the overlying soft tissues, and exposure
[15, 16].
Hydroxyapatite is a biocompatible alloplast and a pro-
ven alternative for augmentation of the facial skeleton,
having been used and studied for over two decades [10, 17–
19]. Hydroxyapatite, a calcium phosphate compound
[Ca10(PO4)6(OH)2], is the major mineral component of
bone [9, 20–23] (Fig. 1). The porous, coral-derived type
(Interpore 200, Interpore Orthopaedics, Inc., Irvine, CA) is
formed by a hydrothermal exchange reaction of marine
coral through the conversion of calcium carbonate coral to
hydroxyapatite, which maintains the natural porous
superstructure [17, 18]. Porous hydroxyapatite for aug-
mentation is available in both granule and block form. The
granular variant is associated with more predictable results
and fewer complications [24]. In addition, the granular
form requires considerably less operative exposure and soft
tissue dissection.
A challenge associated with onlay implants is the pre-
vention of postoperative movement and migration. An
advantage of using hydroxyapatite is the inherent biologi-
cal fixation, which means the graft is not prone to displace,
extrude, or resorb which subsequently improves long-term
results [5]. Previous studies have shown that the porous
form (200 nm diameter) enables fibrovascular and, in some
procedures, bony in-growth [25–27]. Hydroxyapatite is an
alternative to bone grafts in orthognathic surgery and cra-
niofacial reconstruction [28–32] and, in these applications,
becomes subsequently incorporated into natural bone.
Since the porous form of hydroxyapatite has been postu-
lated to grow into bone in specific surgical procedures,
although it is not osteoinductive [9, 19, 23, 27], it resists
infection by creating a vascularized framework through the
granules [16, 33–35]. Since it is biocompatible because it
has the same mineral composition as bone, hydroxyapatite
is also readily incorporated within the subperiosteal layer
without inducing a foreign-body reaction [17, 36–38]. The
advantage of being highly malleable also allows intraop-
erative shaping for the desired result.
Hydroxyapatite is not used as widely as would be
expected for augmentation of facial shape given its proven
qualities of safety, versatility, and long-term use. A possible
reason for this lack of popularity may be the absence of
conclusive data regarding the long-term maintenance of the
augmented volume. To evaluate the long-term fate of porous
hydroxyapatite granules used in augmentation of the facial
skeleton, a prospective radiologic study was performed over
a 2-year follow-up period using thin-slice CT scans.
Materials and Methods
Over a 1-year period (2004–2005), 24 patients underwent
augmentation of the facial skeleton for aesthetic enhance-
ment using porous hydroxyapatite granules (Pro Osteon
200, Interpore Cross International, Irvine, CA). The pro-
cedures were performed by the senior surgeon (BCM). Ten
patients agreed to be part of this prospective study. All were
females between 28 and 58 years (mean = 42.9 years).
Eight patients underwent additional procedures at the
time of the facial skeletal augmentation, including blepha-
roplasty (6), facelift (5), browlift (1), rhinoplasty (1), and
lipoinfiltration (2).
Preoperative planning for the location and quantity of
hydroxyapatite to be used was determined by a trial volume
injection using local anesthetic. The procedures were per-
formed under general anesthesia with systemic antibiotic
coverage (Cephalothin 1 g ? Gentamicin 0.08 g). A precise
subperiosteal pocket was made in the planned area of aug-
mentation. A standard mixture of hydroxyapatite granules,
fibrillar collagen (Spongostan Powder, Johnson & Johnson,
Skipton, UK), and the patient’s blood was prepared
according to the technique recommended by Byrd [24]. An
additional 20% was placed to allow for postoperative com-
paction associated with resolution of the degradable content
of the injected mixture. The subperiosteal hydroxyapatite
was then molded to obtain the desired contour. Several
patients had augmentation at multiple sites.
With consent, ten patients completed three postoperative
CT scans at 3 months, 1 year, and 2 years. All were per-
formed by the same radiologist (ALM) using a GE Light-
speed 16 Multidetector-Row CT scanner (GE Healthcare,
Milwaukee, WI). The patients were scanned supine with
multislice acquisitions obtained in the axial plane through
the relevant section of the face. The images were then
reconstructed at 0.625 mm collimation with isotropic
reconstructions—equivalent thickness to original axial
Fig. 1 Scanning electron micrographs of Pro Osteon 200 hydroxy-
apatite as used in augmentation of the facial skeleton (left) and the
similar physical structure of human cancellous bone (right) (images
courtesy of Interpore Cross International: reproduced with permission)
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acquisitions in coronal, sagittal, and parasaggital planes
(Fig. 2). Three-dimensional facial contour, bone contour,
and volume-rendered reformatted images (Fig. 3) were
completed on the GE AWA workstation. Measurements
were taken in two planes (axial and coronal) where
hydroxyapatite had been placed. Thickness of bone (ori-
ginal bone plus overlay of hydroxyapatite), thickness of the
overlying soft tissue, and the overall projection (bone plus
soft tissue) was recorded in millimeters. Linear measure-
ments were more feasible than volumetric calculations and
would similarly demonstrate the in situ behavior of the
hydroxyapatite granules. The 3-month CT measurements
served as the baseline and these results were compared
with measurements obtained from the precise correspond-
ing images on the 1- and 2-year CT scans.
The measurements acquired from the 1- and 2-year
scans were each divided by the baseline measurement from
the 3-month scan yielding a percentage of the baseline
distance, i.e., 1-year measurement in mm/3-month mea-
surement in mm and 2-year measurement in mm/3-month
measurement in mm (Fig. 4). Statistical analysis was per-
formed on the overall projection, bony thickness, and soft
tissue thickness.
The patients’ clinical charts were reviewed for age,
location of augmentation, volume of hydroxyapatite used at
each site, simultaneous procedures performed, complica-
tions, infection, local reaction, revision procedures, and the
duration of clinical follow-up.
Results
The areas of skeletal augmentation included the prejowl
region over the mandible (10), zygomaticomaxillary (10),
and pyriform (4) regions. The average volume of
hydroxyapatite granule mixture placed at each site was
1.6 ml (range = 0.4–3.5 ml). The radiological evaluation
showed that 99.7% of the hydroxyapatite augmentation
was maintained at 2 years when compared to the 3-month
baseline measurements. The t test showed no statistical
Fig. 2 Axial (left) and coronal
(right) CT images showing
hydroxyapatite overlying the
body of the zygoma (shaded
yellow on patient’s right)
Fig. 3 3-D reconstructed CT
images of the facial skeleton
demonstrating the contour and
thickness of hydroxyapatite
placed over the zygomatic body
(left) and prejowl region of
mandibular body (right)
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difference. There was no radiographic evidence of soft
tissue atrophy or native bone resorption on the 1- and
2-year scans. Overall projection (bony and soft tissue) was
maintained at the 2-year follow-up.
Sequelae were limited to minor bruising, swelling, and
moderate discomfort requiring a limited course of analge-
sia. No infections occurred during the 28 months of mean
follow-up. One patient required a small revision procedure
for aesthetic reasons. A small bulge of incorrectly placed
granules over the mandibular rim was corrected by removal
of localized excess granules and the associated fibrous
tissue through the original incision.
Discussion
Underlying every attractive face is a skeleton that is pro-
portional and well balanced. The unique form of the pro-
jection of the face determines the extent of a person’s
attractiveness [39]. The aesthetic outcome is ultimately
determined by the facial soft tissue being well supported by
a skeletal foundation [4]. Facial balance can be corrected or
enhanced through augmentation of the zygomatic promi-
nence, maxilla, mandible, nose, and supraorbital ridges
[40] to achieve aesthetically pleasing proportions.
Beginning with Snyder’s description of dermal grafts for
treating malar facial agenesis in 1956 [41], many tech-
niques and materials have since been used for augmenta-
tion of the facial skeleton. Osteotomies were introduced to
enhance the morphology of the face [42], and subperiosteal
autogenous bone grafts were utilized for unilateral cor-
rective malarplasty [43, 44]. Alloplastic implants were
soon developed in parallel to these techniques, with Hin-
derer using silicone [45] and Spadafora et al. using
polyethylene [46] for malar augmentation. Other alloplastic
materials used have included ivory, metal, acrylic resins,
and ceramics [16, 47]. Regardless of implant choice, all
implanted materials should possess the basic attributes of
being chemically inert, nontoxic, and incapable of inducing
hypersensitivity or a foreign body reaction.
Combining hydroxyapatite granules with the patient’s
blood and additional collagen (Spongostan Powder) pro-
duces a material that provides the flexibility of tailoring the
shape to the area of correction [24, 25, 27]. The mixture
has a hemostatic effect and apparent resistance to infection
[33]. There is little tendency for granule migration when
the hydroxyapatite mixture is placed in a precise subperi-
osteal pocket [24, 25, 27]. Although the surgeon is required
to custom-make the implant instead of using ‘‘off-the-
shelf’’ alternatives, the need for specific fixation of the
Fig. 4 Axial (top) and
corresponding coronal (bottom)
CT images of the mandibular
body showing the thickness of
the hydroxyapatite maintained
over a 2-year period (shaded
yellow on patient’s right)
Fig. 5 Intraoperative view immediately following placement of
hydroxyapatite on the right maxilla and zygoma (2.8 ml granule
mixture) with subperiosteal midcheek lift. Left side dissected but not
yet augmented or lifted
458 Aesth Plast Surg (2010) 34:455–461
123
implant, such as screws needed for porous polyethylene
implants, is avoided. This is because of the biological
integration of hydroxyapatite. Given the advantages of
limited dissection, minimal morbidity, and minimal risk of
complications, skeletal augmentation using hydroxyapatite
widens the indications for its use so that patients who could
benefit from a small-volume augmentation and are not
candidates for traditional solid implants can reasonably
benefit.
Compaction of the hydroxyapatite granules occurs dur-
ing the first few weeks postsurgery and is completely stable
by 6 months [48], with the postoperative reduction in
projection averaging less than 10% [49, 50]. This is why
baseline scans were obtained at 3 months to accommodate
the anticipated settling and dimensional change.
Although this CT study had only a 2-year follow-up, the
fact that the augmented volume is completely maintained
suggests the result could be permanent. This is confirmed
by other longer-term studies that report that hydroxyapatite
maintains a permanent contour over 4 years, although
those studies were clinical and less objective [6, 51, 52].
Augmentation of the facial skeleton is expected to
become increasingly important as the expectations for
aesthetic surgery results become more sophisticated. Now
that there is no longer the uncertainty about the mainte-
nance of the benefit when hydroxyapatite is used, it is
reassuring that this approach to facial glamorization and
rejuvenation is soundly based (Figs. 5, 6).
Conclusion
This study provides clear radiographic evidence that por-
ous hydroxyapatite granules maintain bony and overall
projection at 2 years when used for augmentation of the
facial skeleton in the aesthetic patient. The completeness of
the volume maintenance, although only over a 2-year fol-
low-up in our study, suggests that the volume enhancement
may be permanent.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Gonzalez-Ulloa M (1974) Building out the malar prominences as
an addition to rhytidectomy. Plast Reconstr Surg 53:293–296
2. Hinderer UT (1975) Malar implants for improvement of the facial
appearance. Plast Reconstr Surg 56:157–165
3. Rees TD, Wood Smith D (1973) Cosmetic facial surgery, 1st edn.
Saunders, Philadelphia
4. Rosen HM (1999) Treatment planning: aesthetic goals. Springer,
New York
5. el Deeb M, Roszkowski M (1988) Hydroxylapatite granules and
blocks as an extracranial augmenting material in rhesus monkeys.
J Oral Maxillofac Surg 46:33–40
6. Holmes RE, Hagler HK (1987) Porous hydroxylapatite as a bone
graft substitute in mandibular contour augmentation: a histo-
metric study. J Oral Maxillofac Surg 45:421–429
Fig. 6 Preoperative (left) and
2-year postoperative (right)
images and corresponding CT
scans (below) following
augmentation of the zygoma in
a 25-year-old female
demonstrating the improvement
of soft tissue projection in the
midface
Aesth Plast Surg (2010) 34:455–461 459
123
7. Morris SA, Jackson IT (1991) The uses and complications of
porous hydroxyapatite and proplast hydroxyapatite. Eur J Plast
Surg 14:85
8. Wolfe SA (1982) Autogenous bone grafts versus alloplastic
material in maxillofacial surgery. Clin Plast Surg 9:539–540
9. Baines FW, Elia FP (1996) Facial skeletal augmentation with
hydroxyapatite granules. Churchill Livingstone, New York
10. Scales JT, Winter GD (1975) Clinical considerations in the
choice of materials for orthopedic internal prostheses. J Biomed
Mater Res 9:167–176
11. Terino EO, Flowers RS (2000) The art of alloplastic facial con-
touring. Mosby, St. Louis, MO
12. Yaremchuk MJ (2007) Atlas of facial implants. Elsevier,
Philadelphia
13. Yaremchuk MJ (2003) Facial skeletal reconstruction using
porous polyethylene implants. Plast Reconstr Surg 111:1818–
1827
14. Yaremchuk MJ (2003) Improving aesthetic outcomes after
alloplastic chin augmentation. Plast Reconstr Surg 112:1422–
1432
15. Pettis GY, Kaban LB, Glowacki J (1990) Tissue response to
composite ceramic hydroxyapatite/demineralized bone implants.
J Oral Maxillofac Surg 48:1068–1074
16. Rubin JP, Yaremchuk MJ (1997) Complications and toxicities of
implantable biomaterials used in facial reconstructive and aes-
thetic surgery. Plast Reconstr Surg 100:1336–1353
17. Hobar PC, Pantaloni M, Byrd HS (2000) Porous hydroxyapatite
granules for alloplastic enhancement of the facial region. Clin
Plast Surg 27:557–569
18. Pollick S, Shors EC, Holmes RE, Kraut RA (1995) Bone for-
mation and implant degradation of coralline porous ceramics
placed in bone and ectopic sites. J Oral Maxillofac Surg 53:915–
922 discussion 922-913
19. Wiese KG, Merten HA (1993) The role of the periosteum in
osteointegration of hydroxyapatite granules. Int J Oral Maxillofac
Surg 22:306–308
20. Jackson IT, Yavuzer R (1999) Hydroxyapatite cement: an alter-
native for craniofacial skeletal contour refinements. Br J Plast
Surg 53:24
21. Jarcho M (1981) Calcium phosphate ceramics as hard tissue
prosthetics. Clin Orthop Relat Res (157):259–278
22. Jarcho M, Kay JF, Gumaer KI, Doremus RH, Drobeck H (1977)
Tissue, cellular and subcellular events at a bone-ceramic
hydroxylapatite interface. J Bioeng 1:79–92
23. Kent JN, Zide MF, Kay JF, Jarcho M (1986) Hydroxylapatite
blocks and particles as bone graft substitutes in orthognathic and
reconstructive surgery. J Oral Maxillofac Surg 44:597–605
24. Byrd HS, Hobar PC, Shewmake K (1993) Augmentation of the
craniofacial skeleton with porous hydroxyapatite granules. Plast
Reconstr Surg 91:15–22 discussion 23-16
25. Byrd HS, Hobar PC (1994) Augmentation of the cheekbones with
porous hydroxyapatite granules. Perspect Plast Surg 8:98
26. Rosen HM, McFarland MM (1990) The biological behavior of
hydroxyapatite implanted into the maxillofacial skeleton. Plast
Reconstr Surg 85:718–723
27. Waite PD, Matukas VJ (1986) Zygomatic augmentation with
hydroxylapatite: a preliminary report. J Oral Maxillofac Surg
44:349–352
28. Cottrell DA, Wolford LM (1998) Long-term evaluation of the use
of coralline hydroxyapatite in orthognathic surgery. J Oral
Maxillofac Surg 56:935–941 discussion 941-932
29. Hiatt WR, Moore DL, Mosby EL, Fain DW (1987) Preformed
hydroxylapatite blocks for palatal grafting in orthognathic sur-
gery. Int J Oral Maxillofac Surg 16:302–304
30. Rosen HM, Ackerman JL (1991) Porous block hydroxyapatite
in orthognathic surgery. Angle Orthod 61:185–191 discussion
192
31. Snyderman CH, Scioscia K, Carrau RL, Weissman JL (2001)
Hydroxyapatite: an alternative method of frontal sinus oblitera-
tion. Otolaryngol Clin North Am 34:179–191
32. Weissman JL, Snyderman CH, Hirsch BE (1996) Hydroxyapatite
cement to repair skull base defects: radiologic appearance. AJNR
Am J Neuroradiol 17:1569–1574
33. Ingram AE Jr, Robinson J, Rohrich RJ (1996) The antibacterial
effect of porous hydroxyapatite granules. Plast Reconstr Surg
98:1119
34. Moreira-Gonzalez A, Jackson IT, Miyawaki T, DiNick V, Ya-
vuzer R (2003) Augmentation of the craniomaxillofacial region
using porous hydroxyapatite granules. Plast Reconstr Surg
111:1808–1817
35. Sari A, Yavuzer R, Ayhan S, Tuncer S, Latifoglu O, Atabay K,
Celebi MC (2003) Hard tissue augmentation of the mandibular
region with hydroxyapatite granules. J Craniofac Surg 14:919–
923
36. Costantino PD, Friedman CD, Jones K, Chow LC, Pelzer HJ,
Sisson GA (1991) Hydroxyapatite cement. I. Basic chemistry and
histologic properties. Arch Otolaryngol Head Neck Surg 117:
379–384
37. Drobeck HP, Rothstein SS, Gumaer KI, Sherer AD, Slighter RG
(1984) Histologic observation of soft tissue responses to
implanted, multifaceted particles and discs of hydroxylapatite. J
Oral Maxillofac Surg 42:143–149
38. Friedman CD, Costantino PD, Jones K, Chow LC, Pelzer JH,
Sisson GA Sr (1991) Hydroxyapatite cement. II. Obliteration and
reconstruction of the cat frontal sinus. Arch Otolaryngol Head
Neck Surg 117:385–389
39. Perrett DI, May KA, Yoshikawa S (1994) Facial shape and
judgements of female attractiveness. Nature 368:239–242
40. Epker BN, Wolford LM (1975) Middle-third facial osteotomies:
their use in the correction of acquired and developmental
dentofacial and craniofacial deformities. J Oral Surg 33:491–
514
41. Snyder CC (1956) Bilateral facial agenesia: Treacher-Collins
syndrome. Am J Surg 92:81–87
42. Tessier P (1967) Osteotomies totales de la face. Syndrome de
courzon, syndrom d’apert: oxycephalies, scaphocephalies, turri-
cephalies. Ann Chir Plast 12:273–286
43. Hinderer UT (1965) Cirugia del perfil de la cara; perfiloplastias.
Ann Acad Med Quir Esp 49:3
44. Hinderer UT (1967) El injerto oseo heterologo de kiel en per-
filoplastias depresiones faciales (indicaciones experiencia). Rev
Lat Am Cir Plast 11:158
45. Hinderer UT (1971) Profileplasty. Int Micr J Aesthet Plast Surg
1:N1
46. Spadafora A, De los Rios E, Toledo Rios R (1971) Flat cheeks.
Polyethylene endoprostheses inserted subperiosteally along the
zygomatic arch. Prensa Med Argent 58:1946–1950
47. Mladick RA (1991) Alloplastic cheek augmentation. Clin Plast
Surg 18:29–38
48. Chang C (1981) Clinical evaluation of hydroxylapatite as an
implant material for alveolar augmentation and in vitro and ani-
mal implant investigations, MS thesis, University of Alabama at
Birmingham
49. Kent JN, Quinn JH, Zide MF, Finger IM, Jarcho M, Rothstein SS
(1982) Correction of alveolar ridge deficiencies with nonresorb-
able hydroxylapatite. J Am Dent Assoc 105:993–1001
50. Meijer HJ, Steen WH, Bosman F, Wittkampf AR (1997)
Radiographic evaluation of mandibular augmentation with
460 Aesth Plast Surg (2010) 34:455–461
123
prefabricated hydroxylapatite/fibrin glue implants. J Oral Max-
illofac Surg 55:138–144 discussion 144-135
51. Hupp JR, McKenna SJ (1988) Use of porous hydroxylapatite
blocks for augmentation of atrophic mandibles. J Oral Maxillofac
Surg 46:538–545
52. Vanassche BJ, Stoelinga PJ, de Koomen HA, Blijdorp PA,
Schoenaers JH (1988) Reconstruction of the severely resorbed
mandible with interposed bone grafts and hydroxylapatite. A
2–3 year follow-up. Int J Oral Maxillofac Surg 17:157–160
Aesth Plast Surg (2010) 34:455–461 461
123
